- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06136793
HomeStyles-Adults of Chinese Heritage
HomeStyles: Shaping HOME Environments and LifeSTYLE Practices to Reduce Cardiometabolic Disease Risk in Adults of Chinese Heritage Living in the United States
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the HomeStyles-China RCT is to determine whether this novel, culturally tailored intervention enables and motivates adults of Chinese heritage living in the United States to shape their home environments and weight-related lifestyle practices (i.e., diet, exercise, sleep) to reduce risk for cardiometabolic disease, related conditions, and systemic inflammation more than those in the control condition. RCT Design CONSORT guidelines extension for social and psychological intervention trials will be used to generate a participant flow diagram and report RCT enrollment and retention data. Interested participants will begin by completing a short eligibility screener survey. Eligible participants who give informed consent will have immediate access to the baseline survey. Those who complete the baseline survey, meet survey plausibility checks, and complete the registration page (e.g., provide name and contact information) will be enrolled in the RCT. Enrolled participants will be systematically randomized by computer by alternating assignment to the experimental or attention control study condition. Recruitment materials and the bona fide treatment to be delivered to the attention control group are designed to blind participant assignment to study condition. Participants will receive intervention materials starting immediately after registration and at weekly intervals for 9 weeks. In week 10 of the study, participants will be invited to take the post survey to assess intervention effects. Approximately 12 weeks after participants complete the post survey, they will be invited to take the follow-up survey to assess longer-term intervention effects. Participants who complete the baseline survey will be invited to provide blood and/or fecal samples; those who consent will have the opportunity to provide samples coincident with the post and follow-up surveys. If the participant does not have a cardiometabolic condition but indicates another adult living in the household has a condition, the other adult also will be recruited to provide blood and/or fecal samples.
Each week of the 9-week intervention, participants will be encouraged to spend about 15 minutes reviewing intervention materials; think about the changes like those suggested in the materials that could help their families; and implement 1 or 2 easy, quick, low-cost changes in their homes. Intervention materials (described in a subsequent section) provided each week for 9 weeks include an electronic informational guide for participants, tracker to list guide-related goals for the week and monitor progress toward them, and 3 to 4 encouraging nudges delivered by text and email.
Participant progress through the RCT will be monitored by project staff by observing their visits to the website. Bilingual staff will be trained in customer service strategies and instructed to quickly address any participant queries using scripted responses to ensure equitable care across study groups. Participants will receive modest stipends that increase in value after they complete each survey. Those consenting to blood and/or fecal analyses also will receive modest stipends increasing in value from baseline, to post, to follow-up.
HomeStyles-China is an intervention program that enables and motivates adults to shape their lifestyle behavioral practices and home environments to create and support optimal health and reduce risk factors for and markers of obesity and related chronic conditions. HomeStyles is designed for adults to implement within their homes in partnership with other family members. The home environment is targeted because it plays a dominant role in families, especially those with children and teens who are developing eating and physical activity patterns and these patterns track across the growing years into adulthood. Adults are the family household food gatekeepers and create the structure/lifestyle environment within the home, and thus, strongly influence health protective behaviors of other family members. In addition, adults need more opportunities to gain relevant, practical, non-judgmental obesity prevention information that is easily implemented in their homes and hectic lifestyles.
Experimental Group Intervention: The HomeStyles experimental group intervention materials (i.e., "Healthy" HomeStyles-China) were designed to be congruent with White House and Institute of Medicine (IOM) recommendations for home-centered obesity prevention interventions and critical elements for effective interventions (e.g., interventions are positive, culturally sensitive, supportive of family interactions; develop realistic, effective plans that empower families). Like HomeStyles for preschoolers and HomeStyles-2 for middle childhood intervention materials, HomeStyles-China experimental group intervention materials provide intensive, interactive, fun, non-judgmental opportunities for adults to shape their home environments and lifestyle practices to protect family health. They also promote positive strategies and changes that adults can control in their environments to reduce risk for cardiometabolic disease and related conditions. A positive approach teaches individuals what they can do (eat more fruits) rather than giving prohibitions (cut out fries). Substantial evidence supports preference for positive messages and the value of promoting positive vs restrictive behaviors to achieve health goals.
Intervention Content. Key factors contributing to cardiometabolic disease risk that can be suitably addressed in the home environment identified for inclusion in the intervention materials are inadequate intake of fruits and vegetables, infrequent family meals, excessive consumption of sugar-sweetened beverages, large portion sizes, irregular breakfast consumption, inadequate intake of whole grain foods, limited physical activity, and inadequate sleep.
Attention Control Intervention The attention control intervention will use bona fide, credible materials that are structurally equivalent to the experimental group. The attention control treatment will be credible in that it focuses on a topic fitting the description of the study recruitment materials (i.e., shaping homes and lifestyles to help families be even happier and healthier) yet providing distinctly different, non-overlapping content (i.e., home safety) devoid of the RCT "active" ingredient (i.e., content related to cardiometabolic disease reduction). The attention control intervention materials include the same components as those used in the experimental group (i.e., instructional guides, trackers, nudges) with the content focused on home safety.
The Safe HomeStyles guides focus on indoor air quality, mold & moisture, hazardous household products, carbon monoxide, home safety, foodborne illness, lead safety, and safe food storage. The Safe HomeStyles materials have an appearance and structure similar to those in the experimental group.
Instruments The study survey, "Home Obesogenicity Measures of EnvironmentS"-Families of Chinese Heritage (HOMES-China), will be used to collect baseline, post, and follow-up data in the RCT. The Social Cognitive Theory along with the key concepts addressed in the HomeStyles-China guides provided the framework for identification of cognitions, behaviors, and aspects of the home environment to be assessed. Online survey collection procedures will be used to collect baseline, post, and follow-up self-report data. The survey will collect sociodemographic characteristics, health status; cardiometabolic health-related cognitions and behaviors; and cardiometabolic health-related characteristics of the home environment. When the participant does not have a cardiometabolic condition but another adult in the family does, sociodemographic characteristics, health status, and cardiometabolic-related health behaviors of the other adult will be collected. A subset of participants (and when applicable, another adult family member) will be invited to provide a blood sample and fecal sample.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Rutgers University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adult of Chinese heritage >30 years with a self-reported cardiometabolic condition or living with an adult (spouse/partner, parent) with a cardiometabolic condition; primary food gatekeeper in the household (i.e., makes all or most decisions related to family food choices); has regular Internet access, read English and/or Chinese, and resides in the United States
Exclusion Criteria:
- Does not fit inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Healthy HomeStyles
Online educational intervention
|
2-arm ~10 week educational intervention
|
|
Active Comparator: Active Comparator: Safe HomeStyles
Online educational intervention
|
2-arm ~10 week educational intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Health-related behaviors: Fruit/Vegetable/Fiber Intake (servings/day)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Dietary intake: Block Fruit/Vegetable/Fiber Screener servings/day; possible range 0 to infinity
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Health-related behaviors: Sugar-sweetened Beverage Intake (servings/day)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Dietary intake: HOMES Sugar-sweetened beverage Intake servings/day; possible range 0 to infinity
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Health-related behaviors: Physical Activity Level
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Physical activity: Streamlined International Physical Activity Questionnaire; possible range 0 to 49; 49 is highest
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Health-related behaviors: Self-Efficacy for Health Behaviors
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
HOMES Self-Efficacy for Engaging in Healthy Cardiometabolic Behaviors; possible score range 1 to 5; 5 is highest
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Markers: Diabetes Risk
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
HbA1c; percentage; normal below 5.7%; prediabetes 5.7 to 6.4%; diabetes 6.5% or above
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Markers: Height (for BMI calculation)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Height (in cm)
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Markers: Weight (for BMI calculation)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Weight (in kg)
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Markers: Waist circumference
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Waist circumference (in cm) for central adiposity assessment
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Health-related Behavior: Sleep duration
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Participant sleep duration: Pittsburgh Sleep Quality Index; Sleep Duration Component; possible score 0 to 24 hours
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Marker: Lipid
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Lipid panel: total cholesterol, triglycerides, HDL, LDL
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Participant Cardiometabolic Disease Marker: Inflammation
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
hsCRP
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Fruit/Vegetable/Fiber Intake (servings/day)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Dietary intake: Block Fruit/Vegetable/Fiber Screener servings/day; possible range 0 to infinity
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Sugar-Sweetened Beverage Intake (servings/day)
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Dietary intake: HOMES Sugar-sweetened beverage Intake servings/day; possible range 0 to infinity
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Physical Activity Level
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Physical activity: Streamlined International Physical Activity Questionnaire; possible range 0 to 49; 49 highest
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Sleep Duration Behaviors
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Other adult sleep duration: Pittsburgh Sleep Quality Index; Sleep Duration Component; possible score 0 to 24 hours
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition Cardiometabolic Disease Markers: Lipid
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Lipid panel: total cholesterol, triglycerides, HDL, LDL
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition Cardiometabolic Disease Markers: Inflammation
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
hsCRP
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition Diabetes Risk
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
HbA1c; percentage; normal below 5.7%; prediabetes 5.7 to 6.4%; diabetes 6.5% or above
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Height
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Height (in cm) for BMI calculation
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Weight
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Weight (in kg) for BMI Calculation
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Waist Circumference
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Waist circumference (in cm) for central adiposity assessment
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Household Supports for cardiometabolic disease reduction measures: Environmental Supports
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
HOMES Environment Supports for Cardiometabolic Health; possible score 1 to 5; 5 highest
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
|
Household Supports for cardiometabolic disease reduction measures: Family Collective-Efficacy
Time Frame: Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
HOMES Family Collective-Efficacy; possible score 1 to 5; 5 highest
|
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Carol Byrd-Bredbenner, Rutgers University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Disease Attributes
- Metabolic Diseases
- Glucose Metabolism Disorders
- Pathological Conditions, Signs and Symptoms
- Behavior
- Nutritional and Metabolic Diseases
- Behavior, Animal
- Hypertension
- Inflammation
- Diabetes Mellitus
- Chronic Disease
- Motor Activity
- Sedentary Behavior
- Feeding Behavior
- Health Behavior
Other Study ID Numbers
- Pro2020001192a
- P50MD017356 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
Clinical Trials on HomeStyles-China
-
University of FloridaUnited States Department of Agriculture (USDA)CompletedCognitive Change | Parent-Child Relations | Parenting | Parents | Child Behavior | Healthy Lifestyle | Home Environment Related Disease | Child ObesityUnited States
-
Procter and GambleCompletedDental Plaque | Dental Gingivitis
-
Peking Union Medical College HospitalUnknownLactate | Severe Sepsis With Septic Shock
-
Shandong UniversityUnknownRecombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in PregnancyPregnancy | Immune ThrombocytopeniaChina
-
Johnson & Johnson Medical (Suzhou) Ltd.CompletedArthritis, Rheumatoid | Osteoarthritis | Post-traumatic; ArthrosisChina
-
Guang'anmen Hospital of China Academy of Chinese...Ministry of Science and Technology of the People´s Republic of ChinaCompletedUrinary Stress IncontinenceChina
-
Rutgers, The State University of New JerseyUnited States Department of Agriculture (USDA)CompletedCognitive Change | Parent-Child Relations | Parenting | Parents | Child Behavior | Healthy Lifestyle | Home Environment Related Disease | Child ObesityUnited States
-
Yonsei UniversityCompletedThe Effect of Transcutaneous Electrical Nerve Stimulation on Posterior Neck Pain After ThyroidectomyNeck Pain | Thyroid CancerKorea, Republic of
-
Shandong UniversityUnknownThrombocytopenia | Acute Myelocytic Leukemia | Antineoplastic Adverse ReactionChina
-
Henan University of Traditional Chinese MedicineUnknownPulmonary Disease, Chronic Obstructive